| 2024-06-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Technical Ops. Off. | 7,288 0.0028% | $478.00 | $3.48M | -0.43% | |
| 2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Technical Ops. Off. | 883 0.0003% | $425.70 | $375,893 | -3.7% | |
| 2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Technical Ops. Off. | 1,201 0.0005% | $421.77 | $506,546 | -0.31% | |
| 2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Technical Ops. Off. | 801 0.0003% | $420.79 | $337,053 | -0.48% | |
| 2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Technical Ops. Off. | 913 0.0004% | $420.24 | $383,679 | +0.03% | |
| 2023-06-01 | Sale | 89bio, Inc. ETNB | director | 6,250 0.0112% | $17.91 | $111,938 | -41.25% | |
| 2023-03-01 | Sale | 89bio, Inc. ETNB | director | 10,000 0.0184% | $13.60 | $136,000 | +8.33% |